Critical Survey: Pro-Dex (NASDAQ:PDEX) vs. Straumann (OTCMKTS:SAUHY)

Pro-Dex (NASDAQ:PDEX) and Straumann (OTCMKTS:SAUHY) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Insider & Institutional Ownership

15.3% of Pro-Dex shares are held by institutional investors. 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Pro-Dex and Straumann”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59 million	1.38	$8.98 million	$2.70	10.40
Straumann	$2.84 billion	6.29	$441.09 million	N/A	N/A

Straumann has higher revenue and earnings than Pro-Dex.

Volatility and Risk

Pro-Dex has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500. Comparatively, Straumann has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Pro-Dex and Straumann, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0	1	1	0	2.50
Straumann	1	2	0	3	2.83

Pro-Dex currently has a consensus price target of $56.00, indicating a potential upside of 99.50%. Given Pro-Dex’s higher possible upside, analysts clearly believe Pro-Dex is more favorable than Straumann.

Profitability

This table compares Pro-Dex and Straumann’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pro-Dex	13.48%	26.67%	14.95%
Straumann	N/A	N/A	N/A

Summary

Pro-Dex beats Straumann on 7 of the 13 factors compared between the two stocks.

About Pro-Dex

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

About Straumann

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.